Skip to main navigation Skip to search Skip to main content

Paclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer.

Translated title of the contribution: Paclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer.
  • G.S. Sonke
  • , I.A. Mandjes
  • , M.J. Holtkamp
  • , M. Schot
  • , E. van Werkhoven
  • , J. Wesseling
  • , M.J. Vrancken Peeters
  • , S. Rodenhuis
  • , S.C. Linn

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPaclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer.
Original languageUndefined/Unknown
Pages (from-to)419-426
Number of pages8
JournalThe Breast Journal
Volume19
Issue number4
Publication statusPublished - 2013

Cite this